Last $9.09 USD
Change Today -0.39 / -4.11%
Volume 343.7K
INO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:42 AM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark L. Bagarazzi M.D.

Chief Medical Officer, Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

53$493,996
As of Fiscal Year 2013

Background*

Mark L. Bagarazzi, M.D. has been the Chief Medical Officer of Inovio Pharmaceuticals, Inc since January 2010. Dr. Bagarazzi leads worldwide clinical development and regulatory activities for Inovio's next-generation vaccines for the treatment and prevention of influenza, HIV, other infectious diseases and cancers. He joined Inovio from Merck & Co., where he was Director of worldwide regulatory affairs for vaccines and biologics. Dr. Bagarazzi led ongoing vaccine product ...

Read Full Background

Corporate Headquarters*

Building 18
Blue Bell, Pennsylvania 19422

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
University of Medicine and Dentistry of New Jersey
BS
New Jersey Institute Of Technology

Other Affiliations*

Annual Compensation*

Salary$307,583
Bonus$106,704
Total Annual Compensation$414,287

Stock Options*

All Other Compensation$8,317
Exercisable Options497,500
Unexercisable Options252,500
Total Number of Options750,000

Total Compensation*

Total Annual Cash Compensation$422,604
Total Short Term Compensation$414,287
Other Long Term Compensation$8,317
Total Calculated Compensation$493,996
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INO:US $9.09 USD -0.39

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$557.7K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.